[go: up one dir, main page]

MXPA03010601A - Derivados de c-furan-2-il-metilamina y c-tiofen-2-il-metilamina sustituidos. - Google Patents

Derivados de c-furan-2-il-metilamina y c-tiofen-2-il-metilamina sustituidos.

Info

Publication number
MXPA03010601A
MXPA03010601A MXPA03010601A MXPA03010601A MXPA03010601A MX PA03010601 A MXPA03010601 A MX PA03010601A MX PA03010601 A MXPA03010601 A MX PA03010601A MX PA03010601 A MXPA03010601 A MX PA03010601A MX PA03010601 A MXPA03010601 A MX PA03010601A
Authority
MX
Mexico
Prior art keywords
methylamine
derivatives
medicament
thiophen
furan
Prior art date
Application number
MXPA03010601A
Other languages
English (en)
Inventor
Przewosny Michael
Original Assignee
Gr Nenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gr Nenthal Gmbh filed Critical Gr Nenthal Gmbh
Publication of MXPA03010601A publication Critical patent/MXPA03010601A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La presente invencion se refiere a derivados de C-furan-2-il-metilamina y C-tiofen-2-il-metilamina sustituidos de la formula general (I), procedimientos para su preparacion, medicamentos composiciones farmaceuticas conteniendolos, asi como su uso para la preparacion de analgesicos, para la preparacion de un anestesico local, de un antiarritmico, un antiemetico, un nootropico y/o de medicamento para el tratamiento y/o la prevencion de enfermedades cardiovasculares, de incontinencia urinaria, diarrea, prurito y/o inflamaciones y/o de un medicamento para el tratamiento de depresiones y/o de abuso de alcohol y/o de drogas y/o de medicamentos y/o de un medicamento para el aumento de alerta.
MXPA03010601A 2001-05-22 2002-05-21 Derivados de c-furan-2-il-metilamina y c-tiofen-2-il-metilamina sustituidos. MXPA03010601A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10125145A DE10125145A1 (de) 2001-05-22 2001-05-22 Substituierte C-Furan-2-yl-methylamin- und C-Thiophen-2-yl-methylamin-Derivate
PCT/EP2002/005542 WO2002094802A1 (de) 2001-05-22 2002-05-21 Substituierte c-furan-2-yl-methylamin- und c-thiophen-2-yl-methylamin-derivate

Publications (1)

Publication Number Publication Date
MXPA03010601A true MXPA03010601A (es) 2004-03-09

Family

ID=7685874

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010601A MXPA03010601A (es) 2001-05-22 2002-05-21 Derivados de c-furan-2-il-metilamina y c-tiofen-2-il-metilamina sustituidos.

Country Status (17)

Country Link
US (2) US6878740B2 (es)
EP (1) EP1392670B1 (es)
JP (1) JP2004532246A (es)
AR (1) AR035982A1 (es)
AT (1) ATE299873T1 (es)
AU (1) AU2002338989B2 (es)
CA (1) CA2448038C (es)
DE (2) DE10125145A1 (es)
DK (1) DK1392670T3 (es)
ES (1) ES2242869T3 (es)
HU (1) HUP0401162A3 (es)
MX (1) MXPA03010601A (es)
PE (1) PE20021099A1 (es)
PL (1) PL367535A1 (es)
PT (1) PT1392670E (es)
SI (1) SI1392670T1 (es)
WO (1) WO2002094802A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0302094D0 (en) * 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) * 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
KR100553398B1 (ko) * 2004-03-12 2006-02-16 한미약품 주식회사 티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체
ES2421723T3 (es) 2009-07-08 2013-09-05 Dermira Canada Inc Análogos de TOFA útiles en el tratamiento de trastornos o afecciones dermatológicas
CN105263473A (zh) * 2013-11-22 2016-01-20 梯瓦优质制药产品研发股份有限公司 可吸入药物
KR101844984B1 (ko) * 2016-05-31 2018-04-03 한림대학교 산학협력단 5원 헤테로사이클릭 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물
CN112521357B (zh) * 2020-08-31 2021-10-08 深圳瑞健生物科技有限公司 一种长效低成瘾性hnk衍生物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3816457A (en) * 1973-01-05 1974-06-11 Richardson Merrell Inc Lactamimide derivatives
US3890445A (en) * 1973-01-05 1975-06-17 Richardson Merrell Inc Lactamimide derivatives useful as hypoglycemic agents
WO2001068816A1 (en) 2000-03-13 2001-09-20 Smithkline Beecham Corporation Human histamine h3 gene variant-3
DE10012820A1 (de) * 2000-03-16 2001-09-20 Bayer Ag Substituierte 1-Aryl-cyclopropylmethylamino-1,3,5-triazine
DE10059864A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate

Also Published As

Publication number Publication date
EP1392670A1 (de) 2004-03-03
US6878740B2 (en) 2005-04-12
JP2004532246A (ja) 2004-10-21
ATE299873T1 (de) 2005-08-15
HUP0401162A2 (hu) 2004-10-28
US20050148550A1 (en) 2005-07-07
PE20021099A1 (es) 2003-01-25
AU2002338989B2 (en) 2007-06-07
US20040152734A1 (en) 2004-08-05
ES2242869T3 (es) 2005-11-16
EP1392670B1 (de) 2005-07-20
PL367535A1 (en) 2005-02-21
CA2448038C (en) 2010-09-28
PT1392670E (pt) 2005-10-31
AR035982A1 (es) 2004-07-28
CA2448038A1 (en) 2002-11-28
DE10125145A1 (de) 2002-11-28
DK1392670T3 (da) 2005-08-08
SI1392670T1 (sl) 2005-12-31
US7317034B2 (en) 2008-01-08
WO2002094802A1 (de) 2002-11-28
HUP0401162A3 (en) 2007-05-02
DE50203686D1 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
AP2088A (en) Phenethanolamine derivatives for treatment of respiratory diseases
MY129422A (en) Medicinal compounds
WO2004037768A3 (en) Phenethanolamine derivatives
UA74346C2 (uk) Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
WO2004037807A3 (en) Medicinal arylethanolamine compounds
MXPA04001307A (es) Compuestos biciclicos aromaticos sustituidos con aminoalquilo, metodo para la produccion de los mismos y su uso como farmacos.
WO2002070510A3 (de) Aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
WO2001085212A3 (en) Drug delivery systems for photodynamic therapy
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
ATE365720T1 (de) Agonisten von beta-adrenorezeptoren
HK1068811A1 (en) Substituted oxazolidinones for combinational therapy
BR0112589A (pt) Derivados de heteroarila e sua aplicação como medicamento
IL164291A0 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
WO2004026306A3 (en) Pyrazole derivatives as transforming growth factor (tgf) inhibitors
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
BR0209276A (pt) Uso da azitromicina para a preparação de um medicamento para tratamento de doenças inflamatórias não infecciosas
WO2001024783A3 (de) Verwendung von (+)-tramadol, o-demethyltramadol bzw. (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol bzw. (+)-o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
MXPA03010601A (es) Derivados de c-furan-2-il-metilamina y c-tiofen-2-il-metilamina sustituidos.
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
BR0210473A (pt) Composição compreendendo um inibidor da pde-4 e antagonista do receptor-h1 e seus usos na produção de um medicamento para o tratamento de doenças respiratórias

Legal Events

Date Code Title Description
FG Grant or registration